Show metadata Hide metadata

(19)

(11)

2 749 867

(13)

(51)

IPC

C07K16/28(2006-01-01)

C07K16/30(2006-01-01)

A61K39/395(2006-01-01)

A61K31/337(2006-01-01)

A61K31/5365(2006-01-01)

A61K31/7048(2006-01-01)

A61K31/7064(2006-01-01)

A61K33/24(2006-01-01)

A61P35/00(2006-01-01)

(21) (22)

Application

2016107005, 2014-07-30

(24)

Start date

2014-07-30

(22)

Actual filing date

2014-07-30

(45)

Published

2021-06-17

(72)

Inventor

Sakhin UgurTyurechi OzlemValter KordenVagner MajkeKrojtsberg MariyaKheker SabineYakobs Shtefan

(73)

Holder

Biontekh AgAstellas Farma Ink.Tron Translatsionale Onkologi An Der Univerzitetsmeditsin Der Jokhannes Gutenberg-Univerzitet Majnts Gemajnnyuttsige Gmbkh

DIAGNOSTICS AND TREATMENT OF CANCER ASSOCIATED WITH CANCER STEM CELLS Russian patent published in 2021 - IPC C07K16/28 C07K16/30 A61K39/395 A61K31/337 A61K31/5365 A61K31/7048 A61K31/7064 A61K33/24 A61P35/00

Abstract RU 2749867 C2

FIELD: biotechnology.

SUBSTANCE: invention relates to the field of biotechnology, in particular to a method for treating or preventing cancer characterized by cancer cells expressing CLDN6, which comprises administering an antibody having the ability to bind to CLDN6 and chemotherapy to an oncological patient.

EFFECT: effective treatment or prevention of cancer characterized by cancer cells expressing CLDN6 due to the synergistic effect of a combination of chemotherapy and antibody.

17 cl, 23 dwg, 1 tbl, 10 ex

Similar patents RU2749867C2

Title	Year	Author	Number
ANTIBODIES USEFUL IN DIAGNOSING CANCER	2018	Mitnakht-Kraus, Rita Fell, Shtefan Valter, Korden Tyuresi, Ozlem Zakhin, Ugur	RU2815883C1
AGENTS FOR THE TREATMENT OF CLAUDINE-EXPRESSING CANCER DISEASES	2013	Sakhin, Ugur Tyurechi, Ezlem Shtadler Kristiane Kholland, Yuliya Ber-Makhmud, Khayat Bajssert, Tim Plyum, Laura Le Gol, Fabris Jendretski, Arne Fidler, Markus	RU2798990C2
MODIFIED CELLS WITH CHIMERIC ANTIGEN RECEPTOR FOR TREATING CANCER EXPRESSING CLDN6	2020	Sahin, Ugur Oehm, Petra Rengstl, Benjamin Reinhard, Katharina Michel, Kristina	RU2826058C2
COMBINATION THERAPY USING ANTIBODIES AGAINST CLAUDIN 18.2 FOR CANCER TREATMENT	2014	Sahin, Ugur Tureci, Ozlem Mitnacht-Kraus, Rita Woell, Stefan Jacobs, Stefan Khajnts, Kornelia	RU2792932C2
ANTIBODIES FOR TREATING CANCER, IN WHICH CLAUDIN 6 IS EXPRESSED	2012	Sahin, Ugur Tuereci, Oezlem Koslowski, Michael Walter, Korden Woell, Stefan Kreuzberg, Maria Hubner, Bernd Erdeljan, Michael Weichel, Michael	RU2816850C2
DRUG CONJUGATES CONTAINING ANTI-CLAUDIN 18.2 ANTIBODIES	2016	Sahin, Ugur Tureci, Ozlem Walter, Korden Kreuzberg, Maria Mitnacht-Kraus, Rita Le Gall, Fabrice Jacobs, Stefan	RU2841168C2
BISPECIFIC TRIVALENT ANTIBODIES BINDING TO CLAUDIN 6 OR CLAUDIN 18.2 AND CD3 FOR THE TREATMENT OF ONCOLOGICAL DISEASES WITH CLAUDIN EXPRESSION	2017	Sakhin, Ugur Shtadler, Kristiane Fisher, Lejla Jendretski, Arne Tyurechi, Ozlem Le Gol, Fabris Krojtsberg, Mariya	RU2798988C2
THERAPY FOR TREATING CANCER, INCLUDING ANTIBODIES AGAINST CLAUDIN 18.2	2014	Sakhin, Ugur Tyurechi, Ezlem	RU2832015C2
THERAPEUTIC RNA FOR OVARIAN CANCER	2020	Sahin, Ugur Weber, David Walter, Carina Barea Roldan, Diana Kuner, Ruprecht Wagner, Meike Suchan, Martin Gangi Maurici, Stefania Hubich-Rau, Stefanie Becker, Rene	RU2832172C2
PREDICTION OF IMMUNOGENICITY OF T-CELL EPITOPES	2014	Sakhin Ugur Tadmor Arbel David Kasl Dzhon Kristofer Begel Sebastyan Lever Martin	RU2724370C2

RU 2 749 867 C2

Authors

Sakhin Ugur

Tyurechi Ozlem

Valter Korden

Vagner Majke

Krojtsberg Mariya

Kheker Sabine

Yakobs Shtefan

Dates

2021-06-17—Published

2014-07-30—Filed